TWO SIGMA ADVISERS, LP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 56 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2021. The put-call ratio across all filers is 0.62 and the average weighting 1.9%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2022$149,000
-47.0%
34,900
-42.2%
0.00%
-100.0%
Q4 2021$281,000
-44.2%
60,336
-52.3%
0.00%0.0%
Q3 2021$504,000
-8.2%
126,359
-1.6%
0.00%0.0%
Q2 2021$549,000
-57.5%
128,359
-57.9%
0.00%
-75.0%
Q1 2021$1,293,000
+9.9%
305,059
+0.6%
0.00%
+33.3%
Q4 2020$1,177,000
-6.4%
303,259
-2.8%
0.00%
-25.0%
Q3 2020$1,257,000
-21.3%
311,859
-16.9%
0.00%
-20.0%
Q2 2020$1,598,000375,2230.01%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders